Self-stabilized CpG DNAs optimally activate human B cells and plasmacytoid dendritic cells

被引:28
作者
Cong, YP [1 ]
Song, SS [1 ]
Bhagat, L [1 ]
Pandey, RK [1 ]
Yu, D [1 ]
Kandimalla, ER [1 ]
Agrawal, S [1 ]
机构
[1] Hybridon Inc, Cambridge, MA 02139 USA
关键词
B-cell proliferation; CpG DNA; DNA secondary structures; dendritic cells; hairpin-loop; IFN-alpha; immune stimulation; immunomodulatory oligonucleotides; phosphorothioate oligos; TLR9;
D O I
10.1016/j.bbrc.2003.09.134
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We recently showed that 5'-terminal secondary structures in CpG DNA affect activity significantly more than those at the 3'-end [Biochem. Biophys. Res. Commun. 306 (2003) 948]. The need for an accessible 5'-end of CpG DNA for activity suggested that the receptor reads the DNA sequence from this end. In continuation of these studies, we have designed immunomodulatory oligonucleotides (IMOs), consisting of a nine-mer stimulatory domain, containing a CpG motif and a hairpin-loop structure at the 3'-end, referred to as self-stabilized CpG DNAs. We studied the ability of self-stabilized CpG DNAs to stimulate human B-cell proliferation and interferon-alpha (IFN-alpha.) secretion in plasmacytoid dendritic cell (pDC) culture assays. Self-stabilized CpG DNAs activated human B cells and induced plasmacytoid dendritic cells to secrete high levels of IFN-alpha. While both stimulatory and secondary structures in CpG DNAs were required for pDC activation, CpG motifs were sufficient to activate B cells. Interestingly, CpG motifs were not required for activity in the hairpin duplex region. Further modifications of the hairpin duplex region with a mixture of oligodeoxynuclcotides and oliao-2'-O-methylribonucleotides in a heteroduplex formation permitted activation of both human B cells and pDCs. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:1133 / 1139
页数:7
相关论文
共 47 条
[1]   Effect of G-rich sequences on the synthesis, purification, hybridization, cell uptake, and hemolytic activity of oligonucleotides [J].
Agrawal, S ;
Iadarola, PL ;
Temsamani, J ;
Zhao, QY ;
Shaw, DR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (18) :2219-2224
[2]   In vivo pharmacokinetics of phosphorothioate oligonucleotides containing contiguous guanosines [J].
Agrawal, S ;
Tan, WT ;
Cai, QY ;
Xie, XW ;
Zhang, RW .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1997, 7 (03) :245-249
[3]   Antisense and/or Immunostimulatory Oligonucleotide Therapeutics [J].
Agrawal, Sudhir ;
Kandimalla, Ekambar R. .
CURRENT CANCER DRUG TARGETS, 2001, 1 (03) :197-209
[4]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[5]   Hsp90 binds CpG oligonucleotides directly:: implications for Hsp90 as a missing link in CpG signaling and recognition [J].
Bandholtz, L ;
Guo, Y ;
Palmberg, C ;
Mattsson, K ;
Ohlsson, B ;
High, A ;
Shabanowitz, J ;
Hunt, DF ;
Jörnvall, H ;
Wigzell, H ;
Agerberth, B ;
Gudmundsson, GH .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (02) :422-429
[6]   CpG penta- and hexadeoxyribonucleotides as potent immunomodulatory agents [J].
Bhagat, L ;
Zhu, FG ;
Yu, D ;
Tang, J ;
Wang, H ;
Kandimalla, ER ;
Zhang, RW ;
Agrawal, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 300 (04) :853-861
[7]   RETRACTED: DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA (Retracted Article) [J].
Chu, WM ;
Gong, X ;
Li, ZW ;
Takabayashi, K ;
Ouyang, HH ;
Chen, Y ;
Lois, A ;
Chen, DJ ;
Li, GC ;
Karin, M ;
Raz, E .
CELL, 2000, 103 (06) :909-918
[8]   The crystal structure of the RNA/DNA hybrid r(GAAGAGAAGC)•d(GCTTCTCTTC) shows significant differences to that found in solution [J].
Conn, GL ;
Brown, T ;
Leonard, GA .
NUCLEIC ACIDS RESEARCH, 1999, 27 (02) :555-561
[9]   Immunopharmacology of CpG DNA [J].
Dalpke, A ;
Zimmermann, S ;
Heeg, K .
BIOLOGICAL CHEMISTRY, 2002, 383 (10) :1491-1500
[10]   Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha [J].
Halpern, MD ;
Kurlander, RJ ;
Pisetsky, DS .
CELLULAR IMMUNOLOGY, 1996, 167 (01) :72-78